BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17516110)

  • 21. Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.
    Park JS; Kim HS; Bae YS; Cheong JH; Rha SY; Noh SH; Kim H
    Jpn J Clin Oncol; 2016 Jun; 46(6):507-16. PubMed ID: 27008850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
    Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
    J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
    Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A
    Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
    Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
    Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.
    Hong L; Han Y; Yang J; Zhang H; Jin Y; Brain L; Li M; Zhao Q
    Gene; 2013 Oct; 529(1):69-72. PubMed ID: 23954221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
    Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
    Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
    Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.
    Bentrem D; Wilton A; Mazumdar M; Brennan M; Coit D
    Ann Surg Oncol; 2005 May; 12(5):347-53. PubMed ID: 15915368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
    Shimura T; Toiyama Y; Tanaka K; Saigusa S; Kitajima T; Kondo S; Okigami M; Yasuda H; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Anticancer Res; 2015 Sep; 35(9):4633-9. PubMed ID: 26254352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.
    Al-Moundhri MS; Al-Hadabi I; Al-Mawaly K; Kumar S; Al-Lawati FA; Bhatnager G; Kuruvila S; Al-Hamdani A; El-Sayed SM; Al-Bahrani B
    Med Oncol; 2012 Sep; 29(3):1739-47. PubMed ID: 22048943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
    Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
    Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
    Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
    J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
    Oh HS; Eom DW; Kang GH; Ahn YC; Lee SJ; Kim JH; Jang HJ; Kim EJ; Oh KH; Ahn HJ
    Gastric Cancer; 2014; 17(3):402-11. PubMed ID: 23955257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
    Yamashita K; Ooki A; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
    Anticancer Res; 2008; 28(1B):435-41. PubMed ID: 18383882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
    Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.